Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles L Bennett

Showing results (111-120 of 331) with videos related to

Pageof 34
Sort By:
Expert Opinion on Drug Safety|June 9, 2016
Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA's adverse event reporting systemDennis W Raisch, John A Rafi, Cheng Chen, et al.
Journal of the National Cancer Institute|July 23, 2013
Primary prophylaxis with hematopoietic colony stimulating factor: insights from a Canadian cost-effectiveness analysisScott A Strassels, Michael Dickson, Leann B Norris, et al.
Urology|June 2, 2018
Editorial CommentZaina P Qureshi, Oliver Sartor, Richard J Ablin, et al.
Journal of Women'S Health (2002)|February 21, 2014
Selection of contraceptive therapy for patients with thrombophilia: a review of the evidenceWhitney D Maxwell, Merna Jacob, Lisa B Spiryda, et al.
Biosimilars (Auckland, New Zealand)|May 16, 2014
Rituximab and biosimilars - equivalence and reciprocityZaina P Qureshi, Jametta S Magwood, Sarveshwari Singh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2004
Cost minimization study of image-guided core biopsy versus surgical excisional biopsy for women with abnormal mammogramsRobert M Golub, Charles L Bennett, Tammy Stinson, et al.
Best Practice & Research. Clinical Haematology|March 29, 2005
Effectiveness of erythropoietin in the treatment of patients with malignancies: methods and preliminary results of a Cochrane reviewJulia F Bohlius, Simon Langensiepen, Andreas Engert, et al.
Onkologie|June 27, 2009
Upping recruitment in clinical trials: are the costs worth it?June M McKoy, Athena T Samaras, Thanh H Luu, et al.
The Lancet. Oncology|March 11, 2015
Japanese regulatory authority's perspective on biosimilars - authors' replyCharles L Bennett, Brian Chen, Terhi Hermanson, et al.
Transplantation|October 5, 2002
TTP/HUS occurring in a simultaneous pancreas/kidney transplant recipient after clopidogrel treatment: evidence of a nonimmunological etiologyAndrew M Evens, Hau C Kwaan, Dixon B Kaufman, et al.
Pageof 34

Showing results (111-120 of 331) with videos related to

Sort By:
Pageof 34
Expert Opinion on Drug Safety|June 9, 2016
Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA's adverse event reporting systemDennis W Raisch, John A Rafi, Cheng Chen, et al.
Journal of the National Cancer Institute|July 23, 2013
Primary prophylaxis with hematopoietic colony stimulating factor: insights from a Canadian cost-effectiveness analysisScott A Strassels, Michael Dickson, Leann B Norris, et al.
Urology|June 2, 2018
Editorial CommentZaina P Qureshi, Oliver Sartor, Richard J Ablin, et al.
Journal of Women'S Health (2002)|February 21, 2014
Selection of contraceptive therapy for patients with thrombophilia: a review of the evidenceWhitney D Maxwell, Merna Jacob, Lisa B Spiryda, et al.
Biosimilars (Auckland, New Zealand)|May 16, 2014
Rituximab and biosimilars - equivalence and reciprocityZaina P Qureshi, Jametta S Magwood, Sarveshwari Singh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2004
Cost minimization study of image-guided core biopsy versus surgical excisional biopsy for women with abnormal mammogramsRobert M Golub, Charles L Bennett, Tammy Stinson, et al.
Best Practice & Research. Clinical Haematology|March 29, 2005
Effectiveness of erythropoietin in the treatment of patients with malignancies: methods and preliminary results of a Cochrane reviewJulia F Bohlius, Simon Langensiepen, Andreas Engert, et al.
Onkologie|June 27, 2009
Upping recruitment in clinical trials: are the costs worth it?June M McKoy, Athena T Samaras, Thanh H Luu, et al.
The Lancet. Oncology|March 11, 2015
Japanese regulatory authority's perspective on biosimilars - authors' replyCharles L Bennett, Brian Chen, Terhi Hermanson, et al.
Transplantation|October 5, 2002
TTP/HUS occurring in a simultaneous pancreas/kidney transplant recipient after clopidogrel treatment: evidence of a nonimmunological etiologyAndrew M Evens, Hau C Kwaan, Dixon B Kaufman, et al.
Pageof 34